Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

The concept of a meme stock was born about five years ago. It refers to a publicly traded company that gains substantial market value practically overnight (sometimes literally) due to significant ...

Steve Ottman was born to sell Christmas trees. Ottman, 73, said his family has been growing the holiday staple in Wisconsin since the Great Depression. But now his 50-acre Christmas tree farm just ...

Estrella Luna-Diez receives funding from UK Research & Innovation (UKRI) and the Natural Environment Research Council (NERC). Anne-Marie Culhane receives funding from UKRI and the NERC. Bruno Barcante ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...

First lady Melania Trump will receive the official White House Christmas for 2025 on Nov. 24, marking the first time a Michigan farm has provided the iconic holiday staple in more than four decades.